Current Liabilities Endring Dato
AbbVie USD 34.77B 2.53B 2023-09
Alnylam Pharmaceuticals USD 967.79M 18M 2023-12
Amarin USD 266.69M 4.24M 2023-09
AstraZeneca USD 28.59B 2.21B 2023-09
Esperion Therapeutics USD 137.71M 30.54M 2023-09
GlaxoSmithKline GBP 22.39B 282M 2023-09
Halozyme Therapeutics USD 112.49M 2.69M 2023-12
Heron Therapeutics USD 79.74M 6.98M 2023-09
Ionis Pharmaceuticals USD 448.09M 43.88M 2023-12
Nektar Therapeutics USD 52.11M 1.42M 2023-09
Neurocrine Biosciences USD 691.6M 109.1M 2023-09



Amarin Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.